ChemMedChem, ISSN 1860-7179, 8/2014, Volume 9, Issue 8, pp. 1677 - 1682
Of the five G-protein-coupled muscarinic acetylcholine receptors (mAChRs or M 1 -M 5 ), M 5 is the least explored and understood due to a lack of mAChR subtype...
muscarinic | acetylcholine | antagonist | orthosteric
muscarinic | acetylcholine | antagonist | orthosteric
Journal Article
2.
Full Text
Aiming for allosterism: Evaluation of allosteric modulators of CB 1 in a neuronal model
Pharmacological Research, ISSN 1043-6618, 07/2015, Volume 99, pp. 370 - 376
Cannabinoid pharmacology has proven nettlesome with issues of promiscuity a common theme among both agonists and antagonists. One recourse is to develop...
Allosteric | Depolarization-induced suppression of excitation | Excitatory postsynaptic current | Allosterism | Orthosteric | Cannabinoid | Tetrahydrocannabinol
Allosteric | Depolarization-induced suppression of excitation | Excitatory postsynaptic current | Allosterism | Orthosteric | Cannabinoid | Tetrahydrocannabinol
Journal Article
FEBS Letters, ISSN 0014-5793, 12/2014, Volume 588, Issue 24, pp. 4613 - 4619
Despite the physiological and pharmacological importance of the α -adrenoreceptor, the mode of interactions of classical agonists and radioactive ligands with...
Epinephrine | HEAT | Prazosin | Binding study | Adrenoceptor | Orthosteric site
Epinephrine | HEAT | Prazosin | Binding study | Adrenoceptor | Orthosteric site
Journal Article
ACS Chemical Neuroscience, ISSN 1948-7193, 09/2012, Volume 3, Issue 12, pp. 1025 - 1036
We previously reported the discovery of VU0364572 and VU0357017 as M1-selective agonists that appear to activate M1 through actions at an allosteric site....
GPCR | allosteric | Acetylcholine | agonist | antagonist | orthosteric
GPCR | allosteric | Acetylcholine | agonist | antagonist | orthosteric
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2017, Volume 60, Issue 4, pp. 1478 - 1494
The development of bitopic ligands directed toward D2-like receptors has proven to be of particular interest to improve the selectivity and/or affinity of...
synthon | dopamine D2 receptor | β-arrestin | secondary pharmacophore | orthosteric binding site | primary pharmacophore | bitopic ligand | cyclopropyl | antagonist | dopamine D3 receptor | allosteric modulator
synthon | dopamine D2 receptor | β-arrestin | secondary pharmacophore | orthosteric binding site | primary pharmacophore | bitopic ligand | cyclopropyl | antagonist | dopamine D3 receptor | allosteric modulator
Journal Article
6.
Full Text
Towards understanding the structural basis of partial agonism at the dopamine D3 receptor
Journal of medicinal chemistry, ISSN 0022-2623, 1/2017, Volume 60, Issue 2, pp. 580 - 593
Both dopamine D 3 receptor (D 3 R) partial agonists and antagonists have been implicated as potential medications for substance use disorders. In contrast to...
synthon | partial agonist | Dopamine D3 receptor | orthosteric binding site | molecular dynamics | antagonist | phenylpiperazine
synthon | partial agonist | Dopamine D3 receptor | orthosteric binding site | molecular dynamics | antagonist | phenylpiperazine
Journal Article
Current Drug Targets, ISSN 1389-4501, 05/2012, Volume 13, Issue 5, pp. 594 - 601
Journal Article
Pesticide Biochemistry and Physiology, ISSN 0048-3575, 10/2018, Volume 151, pp. 47 - 52
Neonicotinoid insecticides interact with the orthosteric sites of nicotinic acetylcholine receptors (nAChRs) formed at the interfaces of (a) two adjacent α...
Neonicotinoid | Imidacloprid | Orthosteric binding site | Thiacloprid | Nicotinic acetylcholine receptor | α subunit
Neonicotinoid | Imidacloprid | Orthosteric binding site | Thiacloprid | Nicotinic acetylcholine receptor | α subunit
Journal Article
Chemical and Pharmaceutical Bulletin, ISSN 0009-2363, 2018, Volume 66, Issue 1, pp. 37 - 44
Among the muscarinic acetylcholine receptor (mAChR) subtypes, the M4 receptor has been investigated as a promising drug target for the treatment of...
Journal Article
CURRENT PHARMACEUTICAL DESIGN, ISSN 1381-6128, 2019, Volume 25, Issue 7, pp. 817 - 831
Modulating cellular processes through extracellular chemical stimuli is medicinally an attractive approach to control disease conditions. GPCRs are the most...
LIGAND-BINDING | 2ND EXTRACELLULAR LOOP | interaction model | SITE-DIRECTED MUTAGENESIS | allosteric ligands | A RECEPTOR | BIASED AGONISM | ALLOSTERIC COMMUNICATION PIPELINES | PROTEIN-COUPLED RECEPTOR | STRUCTURAL BASIS | GPCR | FUNCTIONAL SELECTIVITY | PHARMACOLOGY & PHARMACY | Adenosine receptor | receptor conformations | A(2A) RECEPTOR | modulators | orthosteric
LIGAND-BINDING | 2ND EXTRACELLULAR LOOP | interaction model | SITE-DIRECTED MUTAGENESIS | allosteric ligands | A RECEPTOR | BIASED AGONISM | ALLOSTERIC COMMUNICATION PIPELINES | PROTEIN-COUPLED RECEPTOR | STRUCTURAL BASIS | GPCR | FUNCTIONAL SELECTIVITY | PHARMACOLOGY & PHARMACY | Adenosine receptor | receptor conformations | A(2A) RECEPTOR | modulators | orthosteric
Journal Article
Pure and Applied Chemistry, ISSN 0033-4545, 2019, Volume 91, Issue 10, pp. 1641 - 1650
The role of muscarinic receptors has been largely documented over the past few decades. Recently we demonstrated that the activation of M2 muscarinic receptors...
neuroblastoma | orthosteric ligand | cell proliferation | Eurasia 2018 | M2 receptors | survival | RECEPTOR ACTIVATION | PROLIFERATION | CYCLE PROGRESSION | CHEMISTRY, MULTIDISCIPLINARY
neuroblastoma | orthosteric ligand | cell proliferation | Eurasia 2018 | M2 receptors | survival | RECEPTOR ACTIVATION | PROLIFERATION | CYCLE PROGRESSION | CHEMISTRY, MULTIDISCIPLINARY
Journal Article
Journal of the Serbian Chemical Society, ISSN 0352-5139, 2016, Volume 81, Issue 4, pp. 347 - 356
A series of sixteen novel substituted piperidines and (2-methoxyphenyl)piperazines were synthesized, starting from the key intermediates...
Allosteric | Dopamine D | receptor | Docking analysis | Orthosteric binding site | Docking | Dopamine | Synthesis | allosteric | dopamine D2 receptor | orthosteric bind site | docking analysis
Allosteric | Dopamine D | receptor | Docking analysis | Orthosteric binding site | Docking | Dopamine | Synthesis | allosteric | dopamine D2 receptor | orthosteric bind site | docking analysis
Journal Article
Cancers, ISSN 2072-6694, 10/2019, Volume 11, Issue 10, p. 1577
Autotaxin (ATX) is a secreted lysophospholipase D, catalysing the conversion of lysophosphatidylcholine (LPC) to bioactive lysophosphatidic acid (LPA). LPA...
allosteric | lysophosphatidic acid | inhibitor | autotaxin | gpcr | orthosteric | lipid chaperone | signalling
allosteric | lysophosphatidic acid | inhibitor | autotaxin | gpcr | orthosteric | lipid chaperone | signalling
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2014, Volume 289, Issue 3, pp. 1649 - 1661
Background: Extracellular Ca2+ alters mGluR1 activity but by an unknown mechanism. Results: Mutations in predicted Ca2+-binding sites modulated the potency of...
MOLECULAR-MECHANISM | G Protein-coupled Receptors (GPCR) | Allosteric Modulators | DOMAIN | ACTIVATION | ANTAGONIST | Calcium | CPCCOET | BIOCHEMISTRY & MOLECULAR BIOLOGY | Calcium-binding Proteins | Orthosteric Antagonist | IDENTIFICATION | Drug Discovery | STRUCTURAL BASIS | CA2 | CA2+-BINDING SITES | BINDING-SITE | Glutamate Receptors Metabotropic | Orthosteric Agonist | Allosteric Regulation - drug effects | Protein Structure, Tertiary | Glycine - analogs & derivatives | Allosteric Regulation - genetics | Benzoates | Calcium - metabolism | Calcium Signaling - physiology | Humans | Excitatory Amino Acid Agonists - pharmacology | Receptors, Metabotropic Glutamate - metabolism | Mutation, Missense | Receptors, Metabotropic Glutamate - genetics | Calcium Signaling - drug effects | HEK293 Cells | Receptors, Metabotropic Glutamate - agonists | Binding Sites | Receptors, Metabotropic Glutamate - antagonists & inhibitors | Xanthenes - pharmacology | Amino Acid Substitution | Carbamates - pharmacology | Quisqualic Acid - pharmacology | Molecular Biophysics
MOLECULAR-MECHANISM | G Protein-coupled Receptors (GPCR) | Allosteric Modulators | DOMAIN | ACTIVATION | ANTAGONIST | Calcium | CPCCOET | BIOCHEMISTRY & MOLECULAR BIOLOGY | Calcium-binding Proteins | Orthosteric Antagonist | IDENTIFICATION | Drug Discovery | STRUCTURAL BASIS | CA2 | CA2+-BINDING SITES | BINDING-SITE | Glutamate Receptors Metabotropic | Orthosteric Agonist | Allosteric Regulation - drug effects | Protein Structure, Tertiary | Glycine - analogs & derivatives | Allosteric Regulation - genetics | Benzoates | Calcium - metabolism | Calcium Signaling - physiology | Humans | Excitatory Amino Acid Agonists - pharmacology | Receptors, Metabotropic Glutamate - metabolism | Mutation, Missense | Receptors, Metabotropic Glutamate - genetics | Calcium Signaling - drug effects | HEK293 Cells | Receptors, Metabotropic Glutamate - agonists | Binding Sites | Receptors, Metabotropic Glutamate - antagonists & inhibitors | Xanthenes - pharmacology | Amino Acid Substitution | Carbamates - pharmacology | Quisqualic Acid - pharmacology | Molecular Biophysics
Journal Article
Pharmacological Research, ISSN 1043-6618, 03/2018, Volume 129, pp. 475 - 481
The cannabinoid signaling system is found throughout the CNS and its involvement in several pathological processes makes it an attractive therapeutic target....
Allosteric | G protein-coupled receptor | CB1 | Cannabinoid receptor | Orthosteric | TRANSMISSION | PROTEIN | RECEPTOR | PHARMACOLOGY & PHARMACY | cannabinoid receptor | orthosteric
Allosteric | G protein-coupled receptor | CB1 | Cannabinoid receptor | Orthosteric | TRANSMISSION | PROTEIN | RECEPTOR | PHARMACOLOGY & PHARMACY | cannabinoid receptor | orthosteric
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 09/2018, Volume 155, pp. 356 - 365
While many orthosteric ligands have been developed for the mGlu receptor, little is known about their target binding kinetics and how these relate to those of...
Binding kinetics | Glutamate | Allosteric modulation | Orthosteric | mGlu2 receptor | mGlu | receptor | MOLECULAR-MECHANISM | EFFICACY | PHARMACOLOGICAL CHARACTERIZATION | DRUG DISCOVERY | PROTEIN-COUPLED RECEPTORS | MUSCARINIC M-3 RECEPTOR | MAJOR DEPRESSION | TARGET BINDING | mGlu receptor | PHARMACOLOGY & PHARMACY | RAT-BRAIN | MGLU2 RECEPTOR | Amino acids | Drug discovery
Binding kinetics | Glutamate | Allosteric modulation | Orthosteric | mGlu2 receptor | mGlu | receptor | MOLECULAR-MECHANISM | EFFICACY | PHARMACOLOGICAL CHARACTERIZATION | DRUG DISCOVERY | PROTEIN-COUPLED RECEPTORS | MUSCARINIC M-3 RECEPTOR | MAJOR DEPRESSION | TARGET BINDING | mGlu receptor | PHARMACOLOGY & PHARMACY | RAT-BRAIN | MGLU2 RECEPTOR | Amino acids | Drug discovery
Journal Article
Annual Review of Pharmacology and Toxicology, ISSN 0362-1642, 2014, Volume 54, Issue 1, pp. 435 - 456
Protein-protein interactions (PPIs) are critical regulatory events in physiology and pathology, and they represent an important target space for...
Allosteric inhibitors | Interfacial binders | Orthosteric inhibitors | Small-molecule inhibitors | Protein-protein interactions | PPIs | interfacial binders | PYRUVATE-KINASE M2 | DRUG DISCOVERY | protein-protein interactions | AGGRESSIVE CARCINOMA | SIGNAL-TRANSDUCTION | STRUCTURAL BASIS | IN-VIVO | NUCLEOTIDE EXCHANGE FACTOR | CANCER METABOLISM | PHARMACOLOGY & PHARMACY | allosteric inhibitors | BREFELDIN-A | TOXICOLOGY | orthosteric inhibitors | B-RAF | small-molecule inhibitors | SOS1 Protein - antagonists & inhibitors | ras Proteins - genetics | Humans | ras Proteins - metabolism | Molecular Targeted Therapy | Proto-Oncogene Proteins c-akt - genetics | Carrier Proteins - agonists | SOS1 Protein - genetics | Membrane Proteins - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Protein Interaction Domains and Motifs - drug effects | Membrane Proteins - genetics | SOS1 Protein - metabolism | ras Proteins - antagonists & inhibitors | Models, Molecular | Thyroid Hormones - agonists | Thyroid Hormones - genetics | Membrane Proteins - agonists | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Carrier Proteins - genetics | Carrier Proteins - metabolism | Proto-Oncogene Proteins B-raf - genetics | Thyroid Hormones - metabolism | Protein Binding | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Proteins | Protein binding
Allosteric inhibitors | Interfacial binders | Orthosteric inhibitors | Small-molecule inhibitors | Protein-protein interactions | PPIs | interfacial binders | PYRUVATE-KINASE M2 | DRUG DISCOVERY | protein-protein interactions | AGGRESSIVE CARCINOMA | SIGNAL-TRANSDUCTION | STRUCTURAL BASIS | IN-VIVO | NUCLEOTIDE EXCHANGE FACTOR | CANCER METABOLISM | PHARMACOLOGY & PHARMACY | allosteric inhibitors | BREFELDIN-A | TOXICOLOGY | orthosteric inhibitors | B-RAF | small-molecule inhibitors | SOS1 Protein - antagonists & inhibitors | ras Proteins - genetics | Humans | ras Proteins - metabolism | Molecular Targeted Therapy | Proto-Oncogene Proteins c-akt - genetics | Carrier Proteins - agonists | SOS1 Protein - genetics | Membrane Proteins - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Protein Interaction Domains and Motifs - drug effects | Membrane Proteins - genetics | SOS1 Protein - metabolism | ras Proteins - antagonists & inhibitors | Models, Molecular | Thyroid Hormones - agonists | Thyroid Hormones - genetics | Membrane Proteins - agonists | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Carrier Proteins - genetics | Carrier Proteins - metabolism | Proto-Oncogene Proteins B-raf - genetics | Thyroid Hormones - metabolism | Protein Binding | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Proteins | Protein binding
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 10/2018, Volume 391, Issue 10, pp. 1037 - 1052
Firstly, it was determined whether methanthelinium bromide (MB) binds to human M-1-M-5 (hM(1)-hM(5)) muscarinic acetylcholine receptors in comparison to the...
Allosteric | Hyperhidrosis axillaris | Muscarinic receptor | NMS | Orthosteric | Methanthelinium bromide | SUBTYPE | SITE | RADIOLIGAND | ECCRINE SWEAT GLAND | MODULATORS | PROTEIN-COUPLED RECEPTORS | ALLOSTERIC LIGANDS | HYPERHIDROSIS | INHIBITION | PHARMACOLOGY & PHARMACY | ANTAGONISTS
Allosteric | Hyperhidrosis axillaris | Muscarinic receptor | NMS | Orthosteric | Methanthelinium bromide | SUBTYPE | SITE | RADIOLIGAND | ECCRINE SWEAT GLAND | MODULATORS | PROTEIN-COUPLED RECEPTORS | ALLOSTERIC LIGANDS | HYPERHIDROSIS | INHIBITION | PHARMACOLOGY & PHARMACY | ANTAGONISTS
Journal Article
NEUROPHARMACOLOGY, ISSN 0028-3908, 03/2017, Volume 115, pp. 149 - 165
LSP4-2022 is a novel, orthosteric agonist of mGlu(4) receptor that induces antipsychotic-like activity in animal studies. In the present study, the involvement...
Dopamine | Serotonin | PHENCYCLIDINE-INDUCED DOPAMINE | 5-HT1A RECEPTORS | Schizophrenia | SEROTONIN RELEASE | METABOTROPIC GLUTAMATE RECEPTORS | GROUP-III | Glutamate | NEUROSCIENCES | ORTHOSTERIC AGONIST | mGlu | IMMUNOCYTOCHEMICAL LOCALIZATION | PYRAMIDAL NEURONS | GABA | 5-HT1A | MEDIAL PREFRONTAL CORTEX | PHARMACOLOGY & PHARMACY | RAT-BRAIN
Dopamine | Serotonin | PHENCYCLIDINE-INDUCED DOPAMINE | 5-HT1A RECEPTORS | Schizophrenia | SEROTONIN RELEASE | METABOTROPIC GLUTAMATE RECEPTORS | GROUP-III | Glutamate | NEUROSCIENCES | ORTHOSTERIC AGONIST | mGlu | IMMUNOCYTOCHEMICAL LOCALIZATION | PYRAMIDAL NEURONS | GABA | 5-HT1A | MEDIAL PREFRONTAL CORTEX | PHARMACOLOGY & PHARMACY | RAT-BRAIN
Journal Article
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, ISSN 0027-8424, 08/2019, Volume 116, Issue 33, pp. 16347 - 16356
Protein kinase A (PKA) holoenzyme, comprised of a cAMP-binding regulatory (R)-subunit dimer and 2 catalytic (C)-subunits, is the master switch for...
CATALYTIC SUBUNIT | isoform-specific quaternary structure | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | DEPENDENT PROTEIN-KINASE | cAMP | STRUCTURE REVEALS | TARGETED DISRUPTION | I-ALPHA | allosteric and orthosteric regulation | SITE MUTATIONS DEFINE | structural biology | A REGULATORY SUBUNIT | protein kinase A | BETA-SUBUNIT | BINDING | Protein kinase A | Crosstalk | Cyclic AMP | Activation | Kinases | Substrates | Interfaces | Allosteric properties | Isoforms | Dimers | Catalysis | Magnesium | ATP
CATALYTIC SUBUNIT | isoform-specific quaternary structure | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | DEPENDENT PROTEIN-KINASE | cAMP | STRUCTURE REVEALS | TARGETED DISRUPTION | I-ALPHA | allosteric and orthosteric regulation | SITE MUTATIONS DEFINE | structural biology | A REGULATORY SUBUNIT | protein kinase A | BETA-SUBUNIT | BINDING | Protein kinase A | Crosstalk | Cyclic AMP | Activation | Kinases | Substrates | Interfaces | Allosteric properties | Isoforms | Dimers | Catalysis | Magnesium | ATP
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.